247  Total SME IPOs listed in 2024

9572.65 Crs.  Total funds raised in 2024

223  SME IPOs listed with Gain in 2024

24  SME IPOs listed with loss in 2024

247  Total SME IPOs listed in 2024

9572.65 Crs.  Total funds raised in 2024

223  SME IPOs listed with Gain in 2024

24  SME IPOs listed with loss in 2024

247  Total SME IPOs listed in 2024

9572.65 Crs.  Total funds raised in 2024

223  SME IPOs listed with Gain in 2024

24  SME IPOs listed with loss in 2024

247  Total SME IPOs listed in 2024

9572.65 Crs.  Total funds raised in 2024

223  SME IPOs listed with Gain in 2024

24  SME IPOs listed with loss in 2024

Akums Drugs and Pharmaceuticals Limited IPO (Akums Drugs and Pharmaceuticals IPO) Details

Akums Drugs and Pharmaceuticals Limited is an Pharmaceutical based company, located in New Delhi, Akums Drugs and Pharmaceuticals Limited IPO size was 1856.74 Cr. and was issued at 679.00 per share. The share of Akums Drugs and Pharmaceuticals Limited were listed at 796.35 per share and are currently trading at 577.65 per share.

Type :
Sub Sector : Pharmaceuticals
MainBoard IPO

Financial Summary (at the time of ipo, on annualised basis)

Revenue :
4212.21 Cr.

PAT :
0.79 Cr.

Pricing Report

Issue Price :
679.00

Listing Price :
796.35

Current Market Price :
577.65

Issue Price vs CMP :
101.35 (14.93%)

listing Price vs CMP :
218.7 (27.46%)

Performance Report (CAGR* wise)

CAGR : -28.35
-ve 0 6 9 12+
Below Average

*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.

About Akums Drugs and Pharmaceuticals

Company Information
Akums Drugs and Pharmaceuticals Limited is a pharmaceutical contract development and manufacturing organization (CDMO) offering a comprehensive range of pharmaceutical products and services both in India and overseas. As one of the leading CDMOs in India, it owns the intellectual property for the manufacturing processes of several formulations. Its core business focuses on providing end-to-end product development and manufacturing solutions, along with services like formulation research and development (R&D), preparation and filing of regulatory dossiers in both Indian and global markets, and other testing services. Additionally, the company is involved in the manufacturing and sale of branded pharmaceutical formulations and active pharmaceutical ingredients (APIs). In the Financial Year 2023, it was recognized as the largest India-focused CDMO in terms of revenue, production capacity, and
Show More
Object of Issue
  • Repayment/ prepayment of indebtedness of the company and its Subsidiaries
  • Funding incremental working capital requirements of the company
  • Pursuing inorganic growth initiatives through acquisitions and

Akums Drugs and Pharmaceuticals MainBoard IPO Details (at the time of IPO)

IPO Type :
Book Building
IPO Date :
Aug, 2024
IPO Size :
1856.74 Cr.
IPO Subscription :
63.44 X     
PE Multiple :
29.79
Merchant Banker :
Ambit Private Limited
IPO Registrar:
Link Intime India Private Limited

Thinking of
Listing Your Business through
SME IPO?

We can Help!

Contact Us Today

See Other MainBoard IPOs in New Delhi


ACME Solar Holdings Limited

  renewable energy projects and power generation.

  New Delhi


Action Construction Equipment Limited

  construction equipments manufacturing

  New Delhi


Peer Companies Of This Sector

FAQs

Akums Drugs and Pharmaceuticals operates in Pharmaceutical and Pharmaceuticals. The Issue is listed on MainBoard in Aug, 2024. Akums Drugs and Pharmaceuticals IPO size was 1856.74 Cr. with Issue price of 679.00 .

Merchant Banker(s) of Akums Drugs and Pharmaceuticals IPO: Ambit Private Limited , Axis Bank Limited , Citigroup Global Markets India Private Limited , ICICI Securities Limited

Akums Drugs and Pharmaceuticals IPO subscription was 63.44 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.

Akums Drugs and Pharmaceuticals IPO listed at a listing price of 796.35 against the offer price of 679.00.

The current market price of Akums Drugs and Pharmaceuticals is 577.65.

Services

IPO Advisory
IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Readiness
IPO Readiness
IPO Roadmap by improving Business Efficiencies, Financial Parameters and Corporate Structure to become IPO ready.
Fund Raising
Fund Raising
Fuelling a company's growth through Pre IPO Fund Raise, Private Equity, and Angel Investing.
SME : Business Scaling
SME Business Upscaling
Provide support to build a scalable SME business by unleashing the SME potential.
Post IPO Montoring
Post IPO Mentoring
Assisting with post IPO regulatory requirements and Performance Monitoring to achieve the milestone of Mainboard migration.

Thinking of
Listing Your Business through SME IPO?

We can help! Contact Us

Why Us?

  • Leading portal for IPOs
  • End to End Solutions
  • Known for Transparency